Abstract
Methods and software tools for optimal design in nonlinear mixed effect models, based on the Fisher information matrix, have been developed for a decade.1,2 Academic groups regularly proposed new versions.3-5 Present tools do not incorporate adaptive designs for these models although prior information is needed and adaptive designs are increasingly used in drug development.6 We conducted a study among drug companies of the Drug and Disease Model Resources consortium7 to identify current practices and expectations.
| Original language | English |
|---|---|
| Article number | e46 |
| Journal | CPT: Pharmacometrics and Systems Pharmacology |
| Volume | 2 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 1 Jun 2013 |
| Externally published | Yes |